THE INDIAN PHARMACIST Official Circular Pharmacy LogoTHE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
Disease & Clinical Pharmacy Guides • 3-TIER LEARNING GUIDE

Epilepsy & Seizure Disorders: ILAE Classification, ASM Selection, TDM & Teratogenicity

Editorial Body: THE INDIAN PHARMACIST Editorial Reference Reading Time: 9 min read Published: 2026-01-15 Last Updated: 2026-11-08 Status: Evidence-Sourced Educational Guide

1. Level 1 — Quick Learning Overview & Core Definition

Quick Concept Summary: Antiseizure Medication (ASM) selection must be matched precisely to seizure onset classification (Focal-Onset vs Generalised-Onset vs Absence). Narrow-spectrum sodium channel blockers (Carbamazepine, Oxcarbazepine, Phenytoin) are effective for focal-onset seizures but can paradoxically worsen generalised absence and myoclonic seizures, whereas Levetiracetam and Lamotrigine offer broad-spectrum efficacy with markedly lower teratogenic and enzyme-induction liability than Sodium Valproate.

2. Level 2 — Standard Study: Underlying Process & Major Classifications

Epileptogenesis arises from an imbalance between glutamatergic excitatory neurotransmission (mediated by voltage-gated Na+ and Ca2+ channels and AMPA/NMDA receptors) and GABAergic inhibitory tone (mediated by GABA-A chloride channels).

Major Pharmacological & Scientific Classifications

  • Voltage-Gated Na+ Channel Blockers (Phenytoin, Carbamazepine, Oxcarbazepine, Lamotrigine, Lacosamide): Stabilise the inactivated state of neuronal Na+ channels to prevent high-frequency repetitive firing.
  • SV2A Synaptic Vesicle Modulator (Levetiracetam, Brivaracetam): Binds synaptic vesicle protein 2A; minimal protein binding (<10%), zero CYP450 induction/inhibition, renally cleared.
  • Broad-Spectrum Multi-Mechanism Agent (Sodium Valproate / Valproic Acid): Blocks Na+ and T-type Ca2+ channels and increases brain GABA; highest teratogenicity (neural tube defects, neurodevelopmental delay).
  • Absence Seizure Selective T-Type Ca2+ Blocker (Ethosuximide): Inhibits thalamic T-type Ca2+ currents.
  • Status Epilepticus Acute Rescue (Lorazepam IV, Midazolam IM/Buccal, Diazepam IV/PR): Positive allosteric modulators of GABA-A receptors.

3. Original Scientific Illustration (PLATE-8.6: 8.6 Pharmacodynamics: Agonists, Antagonists, Dose-Response Curves & Therapeutic Index)

PHARMACODYNAMICS: AGONISTS, ANTAGONISTS, POTENCY (EC50) VS EFFICACY (Emax) & TI GRADED LOG DOSE–RESPONSE CURVES Log [Drug Concentration / Dose] → % Maximal Effect (E / Emax) Full Agonist (α = 1) + Competitive Antagonist (↑EC50, Same Emax) Partial Agonist (0 < α < 1) + Non-Competitive Antagonist (↓Emax) • Potency = Dose required for 50% effect (EC50 / ED50; horizontal axis) • Efficacy = Maximum ceiling effect achievable (Emax; vertical axis) Clinical Rule: Efficacy (Emax) is clinically more important than Potency. 4 MAJOR RECEPTOR SUPERFAMILIES & THERAPEUTIC INDEX 1. Ligand-Gated Ion Channels (Ionotropic — Milliseconds): GABA_A (Benzodiazepines), Nicotinic AChR, NMDA, 5-HT3 (Ondansetron) 2. G-Protein Coupled Receptors (GPCR / 7-TM — Seconds): Gs (↑cAMP: β1, β2), Gi (↓cAMP: α2, M2, Opioid), Gq (↑IP3/DAG/Ca2+: α1, M1/M3, AT1) 3. Enzyme-Linked / Receptor Tyrosine Kinases (Minutes–Hours): Insulin receptor (PI3K/Akt → GLUT4 translocation), EGFR, VEGFR 4. Intracellular / Nuclear Receptors (Hours–Days, Gene Transcription): Corticosteroids (Prednisolone), Thyroid (T3/T4), Vitamin D, PPAR-γ THERAPEUTIC INDEX (TI = TD50 / ED50) & NTI MONITORING • Wide TI (Safe): Penicillins, Paracetamol (at normal dose), PPIs • Narrow Therapeutic Index (NTI, TI < 2 — Requires TDM): Warfarin (INR), Digoxin, Lithium, Phenytoin, Vancomycin, Aminoglycosides
Figure 8.6: Pharmacodynamic receptor occupancy, intrinsic activity (alpha), Competitive vs Non-Competitive Antagonism, Potency (EC50) vs Efficacy (Emax), and Therapeutic Index (TI = TD50 / ED50).
Diagram Walkthrough: Drug-receptor interaction is governed by two independent parameters: Affinity (the strength of reversible drug-receptor binding, inversely proportional to the dissociation constant Kd) and Intrinsic Activity / Efficacy (alpha, the ability of the bound drug-receptor complex to activate downstream signal transduction). A Full Agonist (alpha = 1, e.g., Morphine at mu-opioid receptors, Adrenaline at beta-adrenoceptors) produces maximal response (Emax = 100%). A Partial Agonist (0 < alpha < 1, e.g., Buprenorphine, Aripiprazole, Pindolol) produces submaximal efficacy even at 100% receptor occupancy and acts as a competitive antagonist in the presence of a full agonist. A Competitive Antagonist (alpha = 0, e.g., Atropine, Naloxone, Losartan) binds reversibly to the orthosteric site, shifting the log dose-response curve to the right (increasing apparent EC50) without reducing Emax. A Non-Competitive or Irreversible Antagonist (e.g., Phenoxybenzamine, Aspirin on platelet COX-1, Omeprazole on H+/K+-ATPase) reduces functional receptor density, depressing Emax.

4. Level 3 — Advanced Clinical, Pharmacokinetic & Regulatory Reference

Non-Linear Zero-Order Kinetics of Phenytoin & Hypoalbuminaemia Correction: Phenytoin undergoes saturable hepatic hydroxylation via CYP2C9 and CYP2C19 (Michaelis-Menten kinetics). Within the therapeutic range (10–20 mcg/mL total phenytoin; 1–2 mcg/mL free unbound phenytoin), hepatic enzymes approach saturation, meaning small dose increments (e.g., 300 mg to 350 mg/day) cause disproportionate, exponential spikes in plasma levels and cerebellar toxicity (nystagmus, ataxia, dysarthria). Because Phenytoin is ~90% bound to serum albumin, patients with hypoalbuminaemia (< 4.0 g/dL) or renal failure require the Sheiner-Tozer correction equation: Corrected Phenytoin = Measured Total Phenytoin / [(0.2 x Albumin) + 0.1] (use 0.1 instead of 0.2 in CrCl < 10 mL/min).

5. Common Misunderstandings & Clinical Pitfalls

Common Misunderstanding: Prescribing Carbamazepine or Phenytoin for childhood absence seizures or juvenile myoclonic epilepsy. Both agents exacerbate absence and myoclonic seizures; Ethosuximide, Lamotrigine, or Levetiracetam should be selected according to syndrome.

6. Key Takeaways, Related Medicine Monographs & Calculators

Key Study & Practice Takeaways:
  • Avoid Sodium Valproate in women and adolescent girls of childbearing potential unless no alternative exists and a strict Pregnancy Prevention Programme is in place.
  • Screen for the HLA-B*15:02 allele in South Asian / Indian populations before initiating Carbamazepine or Phenytoin due to elevated risk of Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis (SJS/TEN).
  • Use the Sheiner-Tozer calculator whenever interpreting total serum phenytoin in hypoalbuminaemic patients.

Related Medicine Monographs

💊 Phenytoin Sodium [11.13] →💊 Escitalopram Oxalate [11.2] → ⚖️ Compare Medicines →

Related Clinical Calculators

🧮 Corrected Calcium & Phenytoin (Sheiner-Tozer) →🧮 Weight-Based Dose Calculator →

7. Authoritative Medical & Regulatory References

  1. Indian Pharmacopoeia Commission (IPC) & CDSCO: Indian Pharmacopoeia (IP 2022) & National List of Essential Medicines (NLEM 2022), Ministry of Health and Family Welfare, Government of India (https://ipc.gov.in/ & https://cdsco.gov.in/).
  2. NCBI Bookshelf / National Library of Medicine: StatPearls Pharmacology, Physiology & Clinical Therapeutics Compendia (https://www.ncbi.nlm.nih.gov/books/).
  3. DailyMed (US National Library of Medicine): Official FDA Prescribing Information & Clinical Pharmacology Labelling (US Jurisdiction Reference) (https://dailymed.nlm.nih.gov/dailymed/).
  4. MedlinePlus, NHS Health Information, Cleveland Clinic Health Library & National Institute on Aging (NIA): Structured patient education and clinical communication references (MedlinePlus • NHS • Cleveland Clinic • NIA).